Kestra Medical Upsizes Public Offering to $138M

Kestra Medical Technologies, a wearable medical device and digital healthcare company, has priced an upsized underwritten public offering of 6M common shares at $23.00 per share, with gross proceeds expected to be $138M. The offering was upsized from an initial 5M shares, indicating strong investor interest in the company. The proceeds will be used to fund the company's growth and expansion plans.